Snta trades as if failure is imminent BUT if they don't cancel ASCO by the day before, I say the drug will show great promise and works well so I would look to buy the day before, betting on a great presentation. If they do cancel then...oh well.
Strange that they would start Phase III recruitment if they anticipated the final Phase II B data was bad. That would be a massive miscalculation.
I hope that won't be the case. Less than a month we'll find out.